NCT02305979View on ClinicalTrials.gov

Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
LeukemiaLymphoma
Interventions
DRUG

Loratadine

Trial Locations (1)

27157

Comprehensive Cancer Center of Wake Forest University, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT02305979 - Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies | Biotech Hunter | Biotech Hunter